post hoc analysis: phase 3 expand trial in secondary progressive ms
Published 4 years ago • 155 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
4:56
post hoc analysis: phase 3 asclepios i and ii trials in relapsing ms
-
5:07
progressive ms: implications of the expand trial
-
5:07
progressive ms: implications of the expand trial
-
2:49
le hua, md: siponimod in secondary progressive multiple sclerosis
-
7:17
expand clinical trial of siponimod for treatment of ms
-
8:24
role of siponimod in multiple sclerosis
-
2:20
phase iii trials of tolebrutinib in relapsing-remitting and progressive ms
-
2:31
actrims 2020 news network: effect of disease duration in the expand study
-
2:54
open-label extension: phase 3 opera i and ii trials in relapsing ms
-
3:57
using virtual placebo to assess long-term effect of siponimod on disability progression in spms
-
1:15:48
midwest cepac: evidence presentation, secondary progressive multiple sclerosis
-
11:36
mis416: clinical trial for secondary progressive ms - the science
-
11:50
mis416: clinical trial for secondary progressive ms - participation
-
5:02
siponimod shows promise for secondary progressive multiple sclerosis
-
4:08
multiple sclerosis: important metrics in clinical trials
-
0:42
secondary progressive ms (spms) - ms in a minute
-
3:51
mis416: clinical trial for secondary progressive ms - preliminary results
-
12:48
progressive ms | ean 2020 summary by multiple sclerosis academy